Peter H. Addy PhD - Salvia: Research and Therapeutic Use

In this episode, Joe interviews Dr. Peter Addy, Licensed Mental Health Counselor out of Washington. In the show, they talk about the research and therapeutic use of Salvia.

3 Key Points:

1. Salvinorin A is the active molecule that causes the psychedelic experiential reports, although there are at least a dozen unique compounds in the Salvia plant.
2. In a recreational setting, Salvia is usually smoked, but in the Mazatec culture, they do not smoke it, they use a sublingual method.
3. The clinical applications of Salvia are tricky right now. It's not easy to get funding for psychedelic research.

Support the show

• Patreon
• Leave us a review on iTunes
• Share us with your friends – favorite podcast, etc
• Join our Facebook group - Psychedelics Today group – Find the others and create community.

Navigating Psychedelics

Show Notes About Peter

• Peter helped found the Yale Psychedelic Speaker Series
  • The main goal was to normalize talking about psychedelic research as research
• Peter joined the pharmacology lab for his post doctoral research on Salvia
  • The team was mainly studying THC but were also studying Ketamine
  • He wanted to bring in MDMA and Psilocybin research
• Peter attended The Institute of Transpersonal Psychology
  • As a psychologist, Peter focused heavily on feedback and experience

Transpersonal Psychology

• It all started when Peter stumbled across a dusty book in the library as a Freshman,